BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23581418)

  • 1. Trends and estimates in prostate cancer incidence, mortality and prevalence in the Slovak Republic, 1968-2012.
    Ondrusova M; Mrozova L; Ondrus D; Mrinakova B
    Neoplasma; 2013; 60(4):446-51. PubMed ID: 23581418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing occurrence of urological cancers in Slovakia.
    Plesko I; Obsitnikova A; Cuninkova M; Tomasek L; Stefanakova D; Kubik A
    Neoplasma; 2004; 51(4):248-54. PubMed ID: 15254654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trends in Prostate Cancer Epidemiology in Slovakia - an International Comparison].
    Ondrušová M; Ondruš D
    Klin Onkol; 2017; 30(2):115-120. PubMed ID: 28397503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in prostate cancer incidence and mortality before and after the introduction of PSA testing in the Slovak and Czech Republics.
    Ondrusova M; Ondrus D; Karabinos J; Muzik J; Kliment J; Gulis G
    Tumori; 2011; 97(2):149-55. PubMed ID: 21617707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008].
    Peng P; Gong YM; Bao PP; Ke JZ; Xiang YM; Zhang ML; Zheng Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1056-9. PubMed ID: 23290851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer incidence and mortality in selected countries of Central Europe.
    Ondrusova M; Muzik J; Kliment J; Gulis G; Ondrus D
    Klin Onkol; 2011; 24(2):126-32. PubMed ID: 21638996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent patterns in stomach cancer descriptive epidemiology in the Slovak Republic with reference to international comparisons.
    Ondrusova M; Ondrus D
    Klin Onkol; 2011; 24(6):447-52. PubMed ID: 22257234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.
    Coldman AJ; Phillips N; Pickles TA
    CMAJ; 2003 Jan; 168(1):31-5. PubMed ID: 12515782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of the projections of incidence rates, prevalence and mortality due to prostate cancer in Aragon (Spain)].
    Bernal M; Romero FJ; Souza DL; Gómez-Bernal FJ; Gómez-Bernal GJ
    Actas Urol Esp; 2011 Sep; 35(8):470-4. PubMed ID: 21621302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of changing trends in prostate cancer incidence and mortality.
    Krongrad A; Lai S; Vidal EM
    Semin Urol Oncol; 1998 Feb; 16(1):30-4. PubMed ID: 9508080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of screening on prostate cancer rates and trends.
    Mettlin C
    Microsc Res Tech; 2000 Dec; 51(5):415-8. PubMed ID: 11074610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rising incidence and mortality of prostate cancer in Belgrade population.
    Janković J; Sipetić S
    Coll Antropol; 2011 Jun; 35(2):499-503. PubMed ID: 21755724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA testing in Austria: induced morbidity and saved mortality.
    Vutuc C; Waldhoer T; Lunglmayr G; Hoeltl W; Haidinger G
    Eur J Cancer Prev; 2009 Sep; 18(5):377-80. PubMed ID: 19512934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
    Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
    J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer incidence and mortality trends in 37 European countries: an overview.
    Bray F; Lortet-Tieulent J; Ferlay J; Forman D; Auvinen A
    Eur J Cancer; 2010 Nov; 46(17):3040-52. PubMed ID: 21047585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in prostate cancer testing and incidence among men under age of 50.
    Li J; German R; King J; Joseph D; Thompson T; Wu XC; Ajani U; Tai E
    Cancer Epidemiol; 2012 Apr; 36(2):122-7. PubMed ID: 22112545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
    Gilliland F; Becker TM; Smith A; Key CR; Samet JM
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer in Czech Republic 1959-1992. Descriptive survey.
    Celko AM
    Cent Eur J Public Health; 1995 Aug; 3(3):119-23. PubMed ID: 8535365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The frequency of cancer in France in 2006, mortality trends since 1950, incidence trends since 1980 and analysis of the discrepancies between these trends].
    Guérin S; Doyon F; Hill C
    Bull Cancer; 2009 Jan; 96(1):51-7. PubMed ID: 19211360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.